Which has higher valuation and earnings, ABT or DXCM?

Abbott Laboratories has higher revenue and earnings than DexCom. Abbott Laboratories is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Abbott Laboratories $44.33B 3.94 $6.52B $3.09 32.69 DexCom $4.66B 7.01 $836.30M $2.53 34.25

Does the media favor ABT or DXCM?

In the previous week, Abbott Laboratories had 12 more articles in the media than DexCom. MarketBeat recorded 21 mentions for Abbott Laboratories and 9 mentions for DexCom. Abbott Laboratories' average media sentiment score of 1.04 beat DexCom's score of 0.73 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 14 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 2 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ISRG or ABT?

In the previous week, Abbott Laboratories had 5 more articles in the media than Intuitive Surgical. MarketBeat recorded 21 mentions for Abbott Laboratories and 16 mentions for Intuitive Surgical. Abbott Laboratories' average media sentiment score of 1.04 beat Intuitive Surgical's score of 0.88 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 6 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Abbott Laboratories 14 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to TSLA or ABT?

In the previous week, Tesla had 194 more articles in the media than Abbott Laboratories. MarketBeat recorded 215 mentions for Tesla and 21 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.04 beat Tesla's score of 0.44 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tesla 66 Very Positive mention(s) 49 Positive mention(s) 59 Neutral mention(s) 27 Negative mention(s) 9 Very Negative mention(s) Neutral Abbott Laboratories 14 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ABBV or ABT?

In the previous week, AbbVie had 19 more articles in the media than Abbott Laboratories. MarketBeat recorded 40 mentions for AbbVie and 21 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.04 beat AbbVie's score of 0.75 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AbbVie 18 Very Positive mention(s) 11 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Abbott Laboratories 14 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ABT or BSX?

In the previous week, Abbott Laboratories had 10 more articles in the media than Boston Scientific. MarketBeat recorded 21 mentions for Abbott Laboratories and 11 mentions for Boston Scientific. Abbott Laboratories' average media sentiment score of 1.04 beat Boston Scientific's score of 0.39 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 14 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Abbott Laboratories (ABT) Competitors

$101.01 +0.03 (+0.03%)

Closing price 03:59 PM Eastern

Extended Trading

$100.85 -0.16 (-0.16%)

As of 05:42 PM Eastern

Compare

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

Should you buy Abbott Laboratories stock or one of its competitors? Abbott Laboratories's main competitors and comparable companies include DexCom (DXCM), Intuitive Surgical (ISRG), Tesla (TSLA), AbbVie (ABBV), and Boston Scientific (BSX). Companies are selected based on similarities in market, industry, and size.

How does Abbott Laboratories compare to DexCom?

Abbott Laboratories (NYSE:ABT) and DexCom (NASDAQ:DXCM) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Abbott Laboratories presently has a consensus target price of $119.50, suggesting a potential upside of 18.30%. DexCom has a consensus target price of $89.08, suggesting a potential upside of 2.82%. Given Abbott Laboratories' stronger consensus rating and higher possible upside, equities analysts clearly believe Abbott Laboratories is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96
DexCom	1 Sell rating(s)	2 Hold rating(s)	20 Buy rating(s)	2 Strong Buy rating(s)	2.92

75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Abbott Laboratories has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, DexCom has a beta of 1.42, suggesting that its stock price is 42% more volatile than the broader market.

In the previous week, Abbott Laboratories had 12 more articles in the media than DexCom. MarketBeat recorded 21 mentions for Abbott Laboratories and 9 mentions for DexCom. Abbott Laboratories' average media sentiment score of 1.04 beat DexCom's score of 0.73 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	14 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	2 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Abbott Laboratories has higher revenue and earnings than DexCom. Abbott Laboratories is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.94	$6.52B	$3.09	32.69
DexCom	$4.66B	7.01	$836.30M	$2.53	34.25

DexCom has a net margin of 20.12% compared to Abbott Laboratories' net margin of 11.65%. DexCom's return on equity of 35.94% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	11.65%	17.69%	9.44%
DexCom	20.12%	35.94%	14.75%

Summary

Abbott Laboratories beats DexCom on 9 of the 16 factors compared between the two stocks.

How does Abbott Laboratories compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and Abbott Laboratories (NYSE:ABT) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	14.47	$2.86B	$8.73	47.21
Abbott Laboratories	$44.33B	3.94	$6.52B	$3.09	32.69

Intuitive Surgical has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market.

Intuitive Surgical presently has a consensus target price of $508.68, indicating a potential upside of 23.41%. Abbott Laboratories has a consensus target price of $119.50, indicating a potential upside of 18.30%. Given Intuitive Surgical's higher possible upside, research analysts plainly believe Intuitive Surgical is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	8 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.68
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

Intuitive Surgical has a net margin of 28.45% compared to Abbott Laboratories' net margin of 11.65%. Abbott Laboratories' return on equity of 17.69% beat Intuitive Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.45%	16.91%	14.83%
Abbott Laboratories	11.65%	17.69%	9.44%

83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.6% of Intuitive Surgical shares are held by insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Abbott Laboratories had 5 more articles in the media than Intuitive Surgical. MarketBeat recorded 21 mentions for Abbott Laboratories and 16 mentions for Intuitive Surgical. Abbott Laboratories' average media sentiment score of 1.04 beat Intuitive Surgical's score of 0.88 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	6 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	14 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Intuitive Surgical beats Abbott Laboratories on 10 of the 17 factors compared between the two stocks.

How does Abbott Laboratories compare to Tesla?

Tesla (NASDAQ:TSLA) and Abbott Laboratories (NYSE:ABT) are related large-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

In the previous week, Tesla had 194 more articles in the media than Abbott Laboratories. MarketBeat recorded 215 mentions for Tesla and 21 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.04 beat Tesla's score of 0.44 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tesla	66 Very Positive mention(s)	49 Positive mention(s)	59 Neutral mention(s)	27 Negative mention(s)	9 Very Negative mention(s)	Neutral
Abbott Laboratories	14 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Tesla has a beta of 1.84, indicating that its share price is 84% more volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market.

Tesla presently has a consensus price target of $410.98, suggesting a potential upside of 16.48%. Abbott Laboratories has a consensus price target of $119.50, suggesting a potential upside of 18.30%. Given Abbott Laboratories' stronger consensus rating and higher possible upside, analysts plainly believe Abbott Laboratories is more favorable than Tesla.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tesla	5 Sell rating(s)	20 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	2.38
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

Abbott Laboratories has a net margin of 11.65% compared to Tesla's net margin of 3.67%. Abbott Laboratories' return on equity of 17.69% beat Tesla's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tesla	3.67%	3.82%	2.27%
Abbott Laboratories	11.65%	17.69%	9.44%

66.2% of Tesla shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 19.9% of Tesla shares are owned by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Abbott Laboratories has lower revenue, but higher earnings than Tesla. Abbott Laboratories is trading at a lower price-to-earnings ratio than Tesla, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tesla	$94.83B	14.70	$3.79B	$1.08	326.70
Abbott Laboratories	$44.33B	3.94	$6.52B	$3.09	32.69

Summary

Abbott Laboratories beats Tesla on 10 of the 17 factors compared between the two stocks.

How does Abbott Laboratories compare to AbbVie?

AbbVie (NYSE:ABBV) and Abbott Laboratories (NYSE:ABT) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

In the previous week, AbbVie had 19 more articles in the media than Abbott Laboratories. MarketBeat recorded 40 mentions for AbbVie and 21 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.04 beat AbbVie's score of 0.75 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AbbVie	18 Very Positive mention(s)	11 Positive mention(s)	8 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	14 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Abbott Laboratories has lower revenue, but higher earnings than AbbVie. Abbott Laboratories is trading at a lower price-to-earnings ratio than AbbVie, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AbbVie	$64.39B	7.23	$4.23B	$3.54	74.45
Abbott Laboratories	$44.33B	3.94	$6.52B	$3.09	32.69

AbbVie currently has a consensus price target of $272.66, suggesting a potential upside of 3.46%. Abbott Laboratories has a consensus price target of $119.50, suggesting a potential upside of 18.30%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Abbott Laboratories is more favorable than AbbVie.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AbbVie	0 Sell rating(s)	6 Hold rating(s)	23 Buy rating(s)	2 Strong Buy rating(s)	2.87
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

AbbVie has a beta of 0.29, meaning that its stock price is 71% less volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

70.2% of AbbVie shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.1% of AbbVie shares are held by insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

AbbVie pays an annual dividend of $6.92 per share and has a dividend yield of 2.6%. Abbott Laboratories pays an annual dividend of $2.52 per share and has a dividend yield of 2.5%. AbbVie pays out 195.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories pays out 81.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. AbbVie has raised its dividend for 53 consecutive years and Abbott Laboratories has raised its dividend for 54 consecutive years.

Abbott Laboratories has a net margin of 11.65% compared to AbbVie's net margin of 9.80%. Abbott Laboratories' return on equity of 17.69% beat AbbVie's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AbbVie	9.80%	-422.07%	14.34%
Abbott Laboratories	11.65%	17.69%	9.44%

Summary

Abbott Laboratories beats AbbVie on 12 of the 20 factors compared between the two stocks.

How does Abbott Laboratories compare to Boston Scientific?

Abbott Laboratories (NYSE:ABT) and Boston Scientific (NYSE:BSX) are both large-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Abbott Laboratories has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market.

Abbott Laboratories has higher revenue and earnings than Boston Scientific. Boston Scientific is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.94	$6.52B	$3.09	32.69
Boston Scientific	$20.07B	3.16	$2.90B	$2.47	17.71

Boston Scientific has a net margin of 17.50% compared to Abbott Laboratories' net margin of 11.65%. Boston Scientific's return on equity of 19.28% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	11.65%	17.69%	9.44%
Boston Scientific	17.50%	19.28%	10.89%

Abbott Laboratories currently has a consensus target price of $119.50, suggesting a potential upside of 18.30%. Boston Scientific has a consensus target price of $70.19, suggesting a potential upside of 60.46%. Given Boston Scientific's higher probable upside, analysts plainly believe Boston Scientific is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96
Boston Scientific	2 Sell rating(s)	6 Hold rating(s)	23 Buy rating(s)	0 Strong Buy rating(s)	2.68

In the previous week, Abbott Laboratories had 10 more articles in the media than Boston Scientific. MarketBeat recorded 21 mentions for Abbott Laboratories and 11 mentions for Boston Scientific. Abbott Laboratories' average media sentiment score of 1.04 beat Boston Scientific's score of 0.39 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	14 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by company insiders. Comparatively, 0.3% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Abbott Laboratories beats Boston Scientific on 11 of the 17 factors compared between the two stocks.

Get Abbott Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ABT vs. The Competition

Export

Metric	Abbott Laboratories	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$174.79B	$5.42B	$7.26B	$22.74B
Dividend Yield	2.49%	1.79%	2.52%	3.68%
P/E Ratio	32.69	25.47	274.72	27.68
Price / Sales	3.94	43.55	606.70	20.20
Price / Cash	14.49	33.37	28.02	19.27
Price / Book	3.33	5.89	10.49	4.64
Net Income	$6.52B	$150.11M	$3.50B	$1.07B
7 Day Performance	-2.61%	-2.50%	-3.03%	-2.80%
1 Month Performance	-10.31%	-5.27%	-4.16%	-5.85%
1 Year Performance	-24.05%	5.79%	13.20%	5.75%

Abbott Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ABT Abbott Laboratories	4.9491 of 5 stars	$101.01 +0.0%	$119.50 +18.3%	-24.5%	$174.79B	$44.33B	32.69	115,000	Positive News
DXCM DexCom	3.3114 of 5 stars	$89.17 -0.2%	$89.08 -0.1%	+29.2%	$33.72B	$4.66B	35.25	11,000
ISRG Intuitive Surgical	4.3182 of 5 stars	$401.65 +2.1%	$508.68 +26.6%	-6.0%	$138.95B	$10.06B	46.01	17,021
TSLA Tesla	4.373 of 5 stars	$375.63 +3.1%	$412.25 +9.7%	-18.8%	$1.44T	$94.83B	347.81	134,785	Trending News Analyst Forecast
ABBV AbbVie	3.8921 of 5 stars	$265.06 +0.4%	$276.64 +4.4%	+20.7%	$466.36B	$61.16B	74.88	57,000	Trending News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ABT) was last updated on 9/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Abbott Laboratories (ABT) Competitors

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

How does Abbott Laboratories compare to DexCom?

Summary

How does Abbott Laboratories compare to Intuitive Surgical?

Summary

How does Abbott Laboratories compare to Tesla?

Summary

How does Abbott Laboratories compare to AbbVie?

Summary

How does Abbott Laboratories compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABT vs. The Competition

Abbott Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Abbott Laboratories (ABT) Competitors

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

How does Abbott Laboratories compare to DexCom?

Do analysts rate ABT or DXCM?

Do insiders & institutionals have more ownership in ABT or DXCM?

Which has more risk and volatility, ABT or DXCM?

Does the media favor ABT or DXCM?

Which has higher valuation and earnings, ABT or DXCM?

Is ABT or DXCM more profitable?

Summary

How does Abbott Laboratories compare to Intuitive Surgical?

Which has stronger valuation & earnings, ISRG or ABT?

Which has more risk and volatility, ISRG or ABT?

Do analysts recommend ISRG or ABT?

Is ISRG or ABT more profitable?

Do insiders and institutionals believe in ISRG or ABT?

Does the media refer more to ISRG or ABT?

Summary

How does Abbott Laboratories compare to Tesla?

Does the media refer more to TSLA or ABT?

Which has more risk & volatility, TSLA or ABT?

Do analysts prefer TSLA or ABT?

Is TSLA or ABT more profitable?

Do institutionals and insiders have more ownership in TSLA or ABT?

Which has higher valuation & earnings, TSLA or ABT?

Summary

How does Abbott Laboratories compare to AbbVie?

Does the media refer more to ABBV or ABT?

Which has better earnings and valuation, ABBV or ABT?

Do analysts rate ABBV or ABT?

Which has more risk & volatility, ABBV or ABT?

Do insiders and institutionals have more ownership in ABBV or ABT?

Is ABBV or ABT a better dividend stock?

Is ABBV or ABT more profitable?

Summary

How does Abbott Laboratories compare to Boston Scientific?

Which has more risk and volatility, ABT or BSX?

Which has higher earnings & valuation, ABT or BSX?

Is ABT or BSX more profitable?

Do analysts recommend ABT or BSX?

Does the media favor ABT or BSX?

Do insiders & institutionals believe in ABT or BSX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABT vs. The Competition

Abbott Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools